The Geneva Association Highlights Challenges and Solutions to Global Pension Gap Epidemic
Leading international think tank of the insurance industry, The Geneva Association, has published a report on the growing pension crisis caused by an ageing population, a drop in fertility and low interest rates in most countries of the world. The Pension Gap Epidemic analyses the scale of the issue, explores possible solutions and suggests eight proposals to address it.
Low fertility rates have put extreme pressure on the old-age-support ratio—defined as the number of workers divided by the number of retirees. The current worldwide old-age-support ratio is about 6.9 workers to retirees but is expected to drop to approximately 3.7 by 2050. For developed countries, the old-age support ratio is forecast to drop further, reaching 2.0 by the year 2050.2
At the same time, life expectancies at age 60 have been improving dramatically in recent decades. Advances in medical technologies and the health benefits of modern life in developed countries will add an estimated 3 years to the life expectancies of those aged 60 by 2050.3
Increased life expectancies and low fertility rates are the two main drivers of the pension gap. However, limited investment returns—a consequence of the Global Financial Crisis in the form of long-term low interest rates—and chronic underfunding by employers, have also exacerbated pension shortfalls significantly. For example, in the U.S., after years of inadequate financing, the U.S. social security funding gap is currently USD 13.4 trillion according to Moody’s Investor Services.4
The Geneva Association estimates the global pension gap to be USD 41 trillion, requiring a combined effort from governments, corporations and the general population to address this epidemic. Cultures and expectations as well as current legislation and legal systems will need to change as part of these reforms.
Ronald Klein, Director of the Global Ageing research programme at The Geneva Association said, “While longer lives are a tremendous human achievement, their occurrence alongside a widespread and persistent drop in fertility rates and inadequate funding is exerting extreme pressure on an already stressed pension system.” He continued, “There is potential to address the issue but the window of opportunity for reform is closing rapidly As populations in most countries continue to age, the political climate will change with them as they favour policies and governments that keep their existing benefits intact.”
The report concludes that no single stakeholder can address this challenge alone and adequate solutions will require a concerted effort (and perhaps compromise) from governments, corporations and individuals alike. The report therefore suggests eight proposals that governments, corporations and the public can take to reduce the pension gap. It also highlights that the insurance industry is in a uniquely strong position as a private sector agent that can support the mitigation of the effects of this epidemic. It has the expertise through its actuaries and underwriters, the tools with its products and services, the appetite to accept risk and the political influence and means to work with governments and society on practical solutions.
For the report, click here.
For the report summary, click here.
Follow the discussion on Twitter with @TheGenevaAssoc, #PensionGap and #retirement and on our LinkedIn company page.
1 These estimates are based upon a 60 per cent wage replacement ratio, Richard Marin’s pension gap calculation in his book Global Pension Crisis: Unfunded Liabilities and how we can Fill the Gap, and an OECD estimate of pay-as-you-go pension funding.
2 United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Ageing 2013. ST/ESA/SER.A/348.
The Geneva Association
+41 789 20 56 77
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Elliott Advisors (UK) Limited Statement on Telecom Italia23.3.2018 07:00 | Pressemelding
Given the momentum behind Elliott's campaign at Telecom Italia to improve both performance and governance, Elliott was not surprised to see yesterday's resignation of seven board members affiliated with Vivendi. Unable to advance any meritorious arguments, the Board has simply abandoned their posts to stall for time. Elliott regards this action as cynical and self-serving, in that it delays the ability of Telecom Italia shareholders to express their votes at the upcoming AGM. This is yet another example of minority shareholder rights at Telecom Italia being abrogated and the continued disregard of corporate governance best practice. Finally, Vivendi should note Elliott's forty-year track record of consistent value creation, and sustained, long-term commitments to expose poor governance and catalyse positive change; Elliott's investment history in Telecom Italia dates back to 1999, well before Vivendi became a shareholder in the Company. About Elliott Elliott Management Corporation mana
Smiths Detection Hold Baggage Scanner Meets Highest Security Standards in EU23.3.2018 07:00 | Pressemelding
The Smiths Detection HI-SCAN 10080 XCT has achieved ECAC approval as a Standard 3.1 explosives detection system for hold baggage – the highest, defined security standard in the EU. This significant advance was made possible by using a dual-view, dual-energy line scanner with high resolution 3D Computed Tomography (CT) to deliver exceptional data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005050/en/ Smiths Detection HI-SCAN 10080 XCT (Graphic: Business Wire) This achievement gives airports currently upgrading to Standard 3 technology, the option to increase detection levels even further to 3.1; and any standard 3 systems already installed can be easily elevated to 3.1 via a software upgrade. The detection algorithms are interchangeable on a bag by bag basis depending on the destination and associated risk level. This offers additional flexibility and productivity. “With the capability to meet detection requirements
Sofinnova Partners Leads SafeHeal’s €6 Million Series a Financing Round23.3.2018 07:00 | Pressemelding
SafeHeal, an early-stage medtech company specialized in digestive surgery and focused on the development of the Colovac device, announces today that it has closed a €6 million Series A financing round led by Sofinnova Partners. Based in Paris, SafeHeal develops an innovative digestive anastomosis protection device, called Colovac, designed to reduce complications and obviate the need for ostomies for colectomy patients. This technology consists of a minimally invasive and fully reversible implant that remains in place until the body’s natural healing and tissue repair processes are complete, for approximately two weeks, after which it is removed. SafeHeal’s device has the potential to radically transform the market while significantly improve patients’ quality of life by enabling them to resume their normal life without having to bear an artificial anus and wear ostomy pouches for several months. About 270,000 colectomy patients receive an ostomy every year in Europe and the USA, repre
Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma23.3.2018 06:00 | Pressemelding
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA) provided a positive opinion for Cabometyx® (cabozantinib) 20, 40, 60 mg for the first-line treatment of adults with intermediate- or poor- risk advanced renal cell carcinoma (aRCC).The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, Executive Vice President, R&D and Chief Scientific Officer said: “Today’s positive opinion from the CHMP is important news for patients with previously untreated advanced renal cell carcinoma, who can shortly benefit from Cabometyx ® as a new first-line treatment option. Following the evidence of its clinical value after a prior VEGF-targeted treatment, we are pleased to be able to expand the benefit of Cabometyx ® for treatment-naïve patients wit
Swiss Wearable Brand MyKronoz Breaks Worldwide Records with its Hybrid Smartwatch ZeTime, on the Sidelines of a Challenging Baselworld 201822.3.2018 16:32 | Pressemelding
On the sidelines of a downsized Baselworld 2018, MyKronoz, the premier watchmaking brand of the smart generation today announces record-breaking crowdfunding results of its hybrid smartwatch ZeTime, with more than $8,000,000 raised in less than a year. The international success of its unique and groundbreaking flagship wearable is followed by the release of a new digital video campaign “I’m a watch; I’m a smartwatch”. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180322005963/en/ MyKronoz ZeTime Petite & Regular top $8M in crowdfunding (Photo: Business Wire) After a historic 35-days Kickstarter campaign launched in March 2017, ZeTime has pursued, since then, its crowdfunding journey on a variety of international and local platforms: Indiegogo, Makuake in Japan, Zec Zec in Taïwan, Wadiz in Korea and on the leading chinese e-commerce website JD.com. Further to this online momentum, MyKronoz has successfully shipped to over 10
Redwood Software Announces First Industry Robotic Licensing Model to Revolutionize Transparent Marketplace Pricing22.3.2018 14:59 | Pressemelding
Redwood Software, the pioneer behind ‘The Robotic Enterprise’, today announced the launch of a revolutionary new robotic licensing model, where customers only pay for the robotic services they consume within their business. Available now, this new licensing model allows customers to directly compare the costs of manual work against processes that are robotized. With the unique Robotic Service Charge, Redwood only charges for the delivery of a robotic service, equivalent to a unit of work that can done by a person (send an email, download a report, reconcile two reports etc.). Redwood delivers a catalogue of 35,000 of these ready built robotic services that can be linked together by business users in a visual plug and play interface. End-to-end business processes can be modelled, robotized, tested and deployed without cost and risk. Only when the robotic service is consumed is a charge made, always replacing work that would otherwise be done manually. Within the Robotic Service Charge,